Cell Culture AutoFlask™
An innovative cell culture flask for automated cell culture systems has been presented by Greiner Bio-One at Analytica 2006 in Munich.Especially developed for automated cell culture systems, the entry route of the AutoFlaskTM does not consist of removable lids or screw caps, which pose reliability, speed and automa-tion problems, but instead the AutoFlaskTM relies solely on a robot accessible entry septum. This multiple entry septum is pre-scored to both prevent coring by pipette tips and ensure sterility of the flask contents throughout solution exchanges.
The external dimensions of the new automation friendly cell culture flask comply with ANSI Standards, rendering it suitable for use on a wide range of cell culture and liquid handling-systems. With a novel design to enable smooth handling during cell seeding, cultivation and subsequent analysis, the AutoFlaskTM features an integrated hydrophobic filter mem-brane to permit unimpeded gas exchange while cultivating cells
The flask also contains a unique centrifugation pocket that enables separation of cells from supernatant while maintaining the integrity of soft pellets.
Greiner Bio-One GmbH - BioScience Group
Based in Frickenhausen, Germany, the BioScience division of Greiner Bio-One International is a leading technol-ogy partner to academia and research institutes, as well as the diagnostic, pharmaceutical and biotechnology industries. This foundation evolved through Greiner Laboratechnik’s ongoing innovative use of modern polymers for laboratory and scientific applications. Today, the BioScience division in conjunction with its sister division Pre-analytics based in Kremsmunster, Austria, has over 1100 employees and generates a turnover in excess of 184.5 million euro per year. With 19 subsidiaries and an established network of sales and distribution partners, the group offers a global presence in over 100 countries. The highly successful BioScience product range provides novel solutions for a wide range of research and diagnostics applications, such as High-Throughput Screening of thera-peutic agents, protein-coated products for cell cultivation, and DNA-Chip developmental technologies.
Genomics Institute of the Novartis Research Foundation (GNF)
Based in San Diego, California’s Torrey Pines research community, the Genomics Institute of the Novartis Re-search Foundation (GNF) has integrated and developed state-of-the-art research technologies, making possible new approaches to understand and target complex biomedical problems. The Institute is funded through the No-vartis Research Foundation which provides GNF the freedom to conduct independent research and technology development. This has allowed GNF to build a technological infrastructure not found in any university or pharma setting, including high throughput screening systems capable of screening millions of compounds per day in bio-chemical or cellular assays, functional genomics systems for genome scale cellular assessments of gene function, and automated protein production, purification and crystallography for high throughput structural genomics. For technology enquiries email: info@gnfsystems.com.
You can receive further information from:
| Greiner Bio-One GmbH Sylvia Bauer und Julia Oster Maybachstraße 2 72636 Frickenhausen Phone: (0 70 22) 948 - 0 Fax: (0 70 22) 948 - 514 marketing@de.gbo.com |
AD VISIO |
Please send us a reprint as documentation when you publish. Thank you.